Cancer Research Institute’s Third Bioinformatics Bootcamp Empowers Scientists with Cutting-Edge Data Analysis Skills for Immunotherapy Breakthroughs
admin San Antonio, Texas – From May 16 to May 22, 2026, the La Cantera Resort...
biotech
Legend Biotech’s In Vivo CAR-T Therapy LB2501 Achieves Full Remissions in Initial Lymphoma Trial, Signaling a Potential Paradigm Shift in Cell Therapy
Shanghai, China – June 3, 2026 – Legend Biotech, a prominent biopharmaceutical company, has announced...
Cancer Research Institute’s Third Annual Bioinformatics Bootcamp Equips Scientists with Crucial Skills for Immunotherapy Advancement
From May 16 to May 22, 2026, the La Cantera Resort in San Antonio, Texas,...
From Experimental Hope to Lived Reality: The Enduring Impact of Immunotherapy on Melanoma Survival
The seemingly mundane rhythms of daily life – school runs, grocery trips, work commitments, family...
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
The pharmaceutical landscape witnessed a dynamic week marked by significant market fluctuations, pivotal regulatory advancements,...
A New Frontier in Colorectal Cancer Immunotherapy: Dr. Karin Pelka Pioneers AI-Driven Research to Transform Outcomes for the Majority of Patients
Colorectal cancer (CRC), encompassing both colon and rectal cancers, represents a formidable challenge in modern...
European Regulators Endorse Sanofi’s Tolebrutinib for Multiple Sclerosis, Diverging from FDA Stance
Sanofi’s experimental multiple sclerosis treatment, tolebrutinib, has received a crucial positive recommendation from European drug...
Unlocking Tomorrow’s Treatments: A Comprehensive Guide to Cancer Clinical Trials and Their Pivotal Role in Advancing Oncology Care
For individuals and families navigating a cancer diagnosis, the term "clinical trial" frequently emerges as...
The Lumanity Cancer Progress 2026 Forum: Charting a Course Beyond Empirical Discovery
Held on April 9th at the distinguished New York Genome Center, Lumanity’s Cancer Progress 2026...
Roche Launches New Global Phase 3 Trial for Elevidys, Revitalizing Bid for European Approval of Duchenne Gene Therapy
The Swiss pharmaceutical giant Roche has announced the initiation of a new global Phase 3...
